4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide for the treatment of Hodgkin's lymphoma

• 收藏
• 分享

专利权人:

Janssen Pharmaceutica NV

发明人:

De Boer, Carla,Elsayed, Yusri A.,Khan, Imran,Manthey, Carl L.,Synder, Linda

申请号：

AU2014235178

公开号：

AU2014235178A1

申请日:

2014.03.13

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

The present invention is directed to methods for the treatment of Hodgkin's lymphoma comprising administering to a patient in need thereof, a therapeutically effective amount of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide as mono-therapy or as combination or co-therapy with one or more chemotherapeutic agent or chemotherapy regimens.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/